Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F21%3A00013196" target="_blank" >RIV/00023736:_____/21:00013196 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1016/S2352-3026(20)30374-4" target="_blank" >https://doi.org/10.1016/S2352-3026(20)30374-4</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S2352-3026(20)30374-4" target="_blank" >10.1016/S2352-3026(20)30374-4</a>
Alternative languages
Result language
angličtina
Original language name
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study
Original language description
Approval of hypomethylating agents in patients with chronic myelomonocytic leukaemia is based on trials done in patients with myelodysplastic syndromes. We aimed to investigate whether hypomethylating agents provide a benefit in subgroups of patients with chronic myelomonocytic leukaemia compared with other treatments.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet haematology
ISSN
2352-3026
e-ISSN
—
Volume of the periodical
8
Issue of the periodical within the volume
2
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
"e135"-"e148"
UT code for WoS article
000614459700012
EID of the result in the Scopus database
2-s2.0-85099709794